Whole blood genome-wide expression profiling and network analysis suggest MELAS master regulators

Area of Science:

• Genomics and Molecular Biology
• Mitochondrial Medicine
• Systems Biology

Background:

• The A3243G mutation in mitochondrial DNA (mtDNA) is a frequent cause of MELAS syndrome.
• Nuclear gene expression reprogramming is crucial for adapting cellular processes to mitochondrial dysfunction in MELAS.
• This adaptation may explain the diverse clinical presentations of MELAS.

Purpose of the Study:

• To identify master regulatory protein networks in MELAS syndrome.
• To discover disease-modifying genes associated with MELAS.
• To understand the nuclear gene expression response to mtDNA mutations.

Main Methods:

• Analysis of whole blood transcriptomes from 10 MELAS patients.
• Integration of Affymetrix microarray data with regulatory and protein interaction network analyses.
• Hierarchical cluster and correlation analyses of gene expression and clinical data.

Main Results:

• Mutant mtDNA load significantly influences nuclear gene expression patterns.
• Novel master regulators, including HIF-1, NF-Y, and CREB-related factors, were identified.
• Disease-modifying genes impacting MELAS phenotype are linked to nucleic acid/protein metabolism and signal transduction, not solely energy metabolism.

Conclusions:

• The study provides a framework for exploring new pathogenetic mechanisms in MELAS.
• Identified regulatory networks and genes offer potential therapeutic targets.
• Understanding nuclear-mitochondrial cross-talk is key to developing MELAS treatments.